Nonetheless, more than 60% of breast cancer patients with genetic characteristics or family aggregation do not carry BRCA1/2 mutations (Telli et al., 2016; Tham et al., 2016; Kwong et al., 2020). This evidence concerns the gene BRCA1 and breast carcinoma.